Jennifer (Jen) is a Director in ATI's Prescription Drug Reimbursement Practice. She focuses on leveraging data to drive coverage and reimbursement strategies. She has a background in health policy, epidemiology, and program management in the prescription drug and medical technology industries.
Prior to joining ATI Advisory, Chen worked for a medical technology startup developing blood-based cancer screening tests, where she supported evidence generation and reimbursement strategy on the market access and medical affairs team. In her previous roles at Memorial Sloan Kettering Cancer Center, she managed a team of policy analysts and the prescription drug pricing research portfolio in the Center for Health Policy and Outcomes and Drug Pricing Lab, and conducted epidemiological research on colorectal cancer for the Cancer Intervention and Surveillance Modeling Network (CISNET) consortium.
Chen holds an MPH in epidemiology and pharmaceuticals management from Boston University School of Public Health and a BS in anthropology from the University of California, Riverside.